Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression

Genes and Development

Volumn 18, Issue 15, 2004, Pages 1800-1805

  Mao, Jian Hua ^a   To, Minh D ^a   Perez Losada, Jesus ^a   Wu, Di ^a   Del Rosario, Reyno ^a   Balmain, Allan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Akt; Carcinoma; Papilloma; Pten; Ras; Skin

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOSITY LOSS; MOUSE; NONHUMAN; ONCOGENE H RAS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CARCINOMA; SKIN PAPILLOMA; SKIN TUMOR; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; DISEASE PROGRESSION; GENES, RAS; HETEROZYGOTE; HOMOZYGOTE; LOSS OF HETEROZYGOSITY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PAPILLOMA; PROTEIN-TYROSINE-PHOSPHATASE; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 3543056881     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1213804     Document Type: Article

References (31)

1. Akhurst, R.J., Fee, F., and Balmain, A. 1988. Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis. Nature 331: 363-365.
2. Balmain, A., Ramsden, M., Bowden, G.T., and Smith, J. 1984. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307: 658-660.
3. Camisa, C., Bikowski, J.B., and McDonald, S.G. 1984. Cowden's disease. Association with squamous cell carcinoma of the tongue and perianal basal cell carcinoma. Arch. Dermatol. 120: 677-678.
4. Chang, F., Steelman, L.S., Shelton, J.G., Lee, J.T., Navolanic, P.M., Blalock, W.L., Franklin, R., and McCubrey, J.A. 2003. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway Int. J. Oncol. 22: 469-480.
5. Cox, A.D. and Der, C.J. 2003. The dark side of Ras: Regulation of apoptosis. Oncogene 22: 8999-9006.
6. Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W., et al. 2002. Mutations of the BRAF gene in human cancer. Nature 417: 949-954.
7. Deng, Q., Liao, R., Wu, B.L., and Sun, P. 2004. High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts. J. Biol. Chem. 279: 1050-1059.
8. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P.P. 1998. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19: 348-355.
9. Groszer, M., Erickson, R., Scripture-Adams, D.D., Lesche, R., Trumpp, A., Zack, J.A., Kornblum, H.I., Liu, X., and Wu, H. 2001. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294: 2186-2189.
10. Hennings, H., Shores, R., Mitchell, P., Spangler, E.F., and Yuspa, S.H. 1985. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 6: 1607-1610.
11. Hildenbrand, C., Burgdorf, W.H., and Lautenschlager, S. 2001. Cowden syndrome-diagnostic skin signs. Dermatology 202: 362-366.
12. Ikeda, T., Yoshinaga, K., Suzuki, A., Sakurada, A., Ohmori, H., and Horii, A. 2000. Anticorresponding mutations of the KRAS and PTEN genes in human endometrial cancer. Oncol. Rep. 7: 567-570.
13. Ise, K., Nakamura, K., Nakao, K., Shimizu, S., Harada, H., Ichise, T., Miyoshi, J., Gondo, Y., Ishikawa, T., Aiba, A., et al. 2000. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene 19: 2951-2956.
14. Kubo, Y., Urano, Y., Hida, Y., and Arase, S. 1999. Lack of somatic mutation in the PTEN gene in squamous cell carcinomas of human skin. J. Dermatol. Sci. 19: 199-201.
15. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947.
16. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M., et al. 1997. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16: 64-67.
17. Marsh, D.J., Dahia, P.L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R.J., and Eng, C. 1997. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16: 333-334.
18. Nagase, H., Mao, J.H., and Balmain, A. 2003. Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Res. 63: 4849-4853.
19. Perez-Losada, J. and Balmain, A. 2003. Stem-cell hierarchy in skin cancer. Nat. Rev. Cancer 3: 434-443.
20. Podsypanina, K., Ellenson, L.H., Nemes, A., Gu, J., Tamura, M., Yamada, K.M., Cordon-Cardo, C., Catoretti, G., Fisher, P.E., and Parsons, R. 1999. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. 96: 1563-1568.
21. Quintanilla, M., Brown, K., Ramsden, M., and Balmain, A. 1986. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322: 78-80.
22. Segrelles, C., Ruiz, S., Perez, P., Murga, C., Santos, C., Budunova, I.V., Martinez, J., Larcher, F., Slaga, T.J., Gutkind, J.S., et al. 2002. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 21: 53-64.
23. INK4a. Cell 88: 593-602.
24. Shan, X., Czar, M.J., Bunnell, S.C., Liu, P., Liu, Y., Schwartzberg, P.L., and Wange, R.L. 2000. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol. Cell. Biol. 20: 6945-6957.
25. Stambolic, V., Suzuki, A., de la Pompa, J.L., Brothers, G.M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J.M., Siderovski, D.P., and Mak, T.W. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39.
26. Steck, P.A., Pershouse, M.A., Jasser, S.A., Yung, W.K., Lin, H., Ligon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T., et al. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15: 356-362.
27. Suzuki, A., Yamaguchi, M.T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., Yoshida, R., Wakeham, A., Higuchi, T., Fukumoto, M., et al. 2001. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14: 523-534.
28. Suzuki, A., Itami, S., Ohishi, M., Hamada, K., Inoue, T., Komazawa, N., Senoo, H., Sasaki, T., Takeda, J., Manabe, M., et al. 2003. Keratinocyte- specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res. 63: 674-681.
29. Tsao, H., Zhang, X., Fowlkes, K., and Haluska, F.G. 2000. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res. 60: 1800-1804.
30. Tsao, H., Goel, V., Wu, H., Yang, G., and Haluska, F.G. 2004. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J. Invest. Dermatol. 122: 337-341.
31. Vivanco, I. and Sawyers, C.L. 2002. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2: 489-501.